| Clinical practice guideline for the use of antimicrobial agents in neutropenic patients with cancer: 2010 update by the Infectious Diseases Society of America AG Freifeld, EJ Bow, KA Sepkowitz, MJ Boeckh, JI Ito, CA Mullen, II Raad, ... Clinical infectious diseases 52 (4), e56-e93, 2011 | 4168 | 2011 |
| Treatment of aspergillosis: clinical practice guidelines of the Infectious Diseases Society of America TJ Walsh, EJ Anaissie, DW Denning, R Herbrecht, DP Kontoyiannis, ... Clinical infectious diseases 46 (3), 327-360, 2008 | 3575 | 2008 |
| Practice guidelines for the diagnosis and management of aspergillosis: 2016 update by the Infectious Diseases Society of America TF Patterson, GR Thompson III, DW Denning, JA Fishman, S Hadley, ... Clinical infectious diseases 63 (4), e1-e60, 2016 | 2774 | 2016 |
| Epidemiology of Aspergillus Infections in a Large Cohort of Patients Undergoing Bone Marrow Transplantation A Wald, W Leisenring, JA van Burik, RA Bowden The Journal of infectious diseases 175 (6), 1459-1466, 1997 | 991 | 1997 |
| Treatment of invasive aspergillosis with posaconazole in patients who are refractory to or intolerant of conventional therapy: an externally controlled trial TJ Walsh, I Raad, TF Patterson, P Chandrasekar, GR Donowitz, R Graybill, ... Clinical infectious diseases 44 (1), 2-12, 2007 | 892 | 2007 |
| Micafungin versus fluconazole for prophylaxis against invasive fungal infections during neutropenia in patients undergoing hematopoietic stem cell transplantation JAH van Burik, V Ratanatharathorn, DE Stepan, CB Miller, JH Lipton, ... Clinical infectious diseases 39 (10), 1407-1416, 2004 | 808 | 2004 |
| Detection and identification of fungal pathogens in blood by using molecular probes H Einsele, H Hebart, G Roller, J Löffler, I Rothenhofer, CA Müller, ... Journal of Clinical Microbiology 35 (6), 1353-1360, 1997 | 781 | 1997 |
| Posaconazole is effective as salvage therapy in zygomycosis: a retrospective summary of 91 cases JAH van Burik, RS Hare, HF Solomon, ML Corrado, DP Kontoyiannis Clinical Infectious Diseases 42 (7), e61-e65, 2006 | 728 | 2006 |
| Posaconazole as salvage therapy for zygomycosis RN Greenberg, K Mullane, JAH Van Burik, I Raad, MJ Abzug, G Anstead, ... Antimicrobial agents and chemotherapy 50 (1), 126-133, 2006 | 668 | 2006 |
| Isavuconazole treatment for mucormycosis: a single-arm open-label trial and case-control analysis FM Marty, L Ostrosky-Zeichner, OA Cornely, KM Mullane, JR Perfect, ... The Lancet infectious diseases 16 (7), 828-837, 2016 | 665 | 2016 |
| A double-blind, randomized, controlled trial of amphotericin B colloidal dispersion versus amphotericin B for treatment of invasive aspergillosis in immunocompromised patients R Bowden, P Chandrasekar, MH White, X Li, L Pietrelli, M Gurwith, ... Clinical infectious diseases 35 (4), 359-366, 2002 | 402 | 2002 |
| Maribavir prophylaxis for prevention of cytomegalovirus disease in recipients of allogeneic stem-cell transplants: a phase 3, double-blind, placebo-controlled, randomised trial FM Marty, P Ljungman, GA Papanicolaou, DJ Winston, RF Chemaly, ... The Lancet infectious diseases 11 (4), 284-292, 2011 | 399 | 2011 |
| Panfungal PCR assay for detection of fungal infection in human blood specimens JA Van Burik, D Myerson, RW Schreckhise, RA Bowden Journal of Clinical Microbiology 36 (5), 1169-1175, 1998 | 374 | 1998 |
| Micafungin (FK463), alone or in combination with other systemic antifungal agents, for the treatment of acute invasive aspergillosis DW Denning, KA Marr, WM Lau, DP Facklam, V Ratanatharathorn, ... Journal of Infection 53 (5), 337-349, 2006 | 347 | 2006 |
| Comparison of six extraction techniques for isolation of DNA from filamentous fungi JAH Van Burik, RW Schreckhise, TC White, RA Bowden, D Myerson Medical mycology 36 (5), 299-303, 1998 | 321 | 1998 |
| Marked increased risk of Epstein-Barr virus-related complications with the addition of antithymocyte globulin to a nonmyeloablative conditioning prior to unrelated umbilical … CG Brunstein, DJ Weisdorf, T DeFor, JN Barker, J Tolar, JAH van Burik, ... Blood 108 (8), 2874-2880, 2006 | 304 | 2006 |
| Aspects of fungal pathogenesis in humans JAH van Burik, PT Magee Annual Reviews in Microbiology 55 (1), 743-772, 2001 | 273 | 2001 |
| Maribavir prophylaxis for prevention of cytomegalovirus infection in allogeneic stem cell transplant recipients: a multicenter, randomized, double-blind, placebo-controlled … DJ Winston, JAH Young, V Pullarkat, GA Papanicolaou, R Vij, E Vance, ... Blood, The Journal of the American Society of Hematology 111 (11), 5403-5410, 2008 | 271 | 2008 |
| Genetic Diversity of Human Pathogenic Members of the Fusarium oxysporum Complex Inferred from Multilocus DNA Sequence Data and Amplified Fragment … K O'Donnell, DA Sutton, MG Rinaldi, KC Magnon, PA Cox, SG Revankar, ... Journal of Clinical Microbiology 42 (11), 5109-5120, 2004 | 270 | 2004 |
| Cutaneous aspergillosis JAH Van Burik, R Colven, DH Spach Journal of clinical microbiology 36 (11), 3115-3121, 1998 | 257 | 1998 |
